Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and ...

Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication ...

Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...

Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

—An analysis of population-based data revealed that males born with DMD experienced prolonged survival when cardiac medication was initiated while LVF was normal, highlighting an area of focus for ...

Ahmedabad: In Gujarat, the sale of cardiac drugs have been growing faster than that of any other drug segment. Market Pulse data of Moving Annual Total (MAT) for January 2026 compiled by Pharmarack ...